RxDoctor Payments Data

Krista Tabler Gresham, NP

Family · Lufkin, TXNPI 1700243730

Payments from drug & device makers

$888in general payments, 2019–2025

Across 45 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$223
  • Lilly USA, LLC$190
  • Novo Nordisk$92
  • Medtronic$88
  • Pfizer$82
  • Ironshore Pharmaceuticals Inc.$54
  • plus $158 from 8 others

What the payments were for

  • Food & beverage$888100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$888 in reported general payments places this provider in the 65th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$19,753
Medicare patients
62
Services billed
589

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide106$120,827
EliquisApixaban28$19,296
JardianceEmpagliflozin16$13,939
Levothyroxine Sodium52$729
Losartan Potassium47$619
Atorvastatin Calcium49$581
Metoprolol Succinate18$299
Trazodone Hcl18$276
Montelukast Sodium15$269
Metformin Hcl20$265
Sertraline Hcl19$248
Lisinopril24$246
Gabapentin18$236
Pantoprazole Sodium21$236
Rosuvastatin Calcium15$219

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$190$120,827106 claims
PfizerEliquis$82$19,29628 claims
Boehringer IngelheimJardiance$16$13,93916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 15,456 family providers in Texas.

Other family in Lufkin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →